Category: wdgyl

Oil prices set for long-term slump as WTI price forecast lowered through 2016

first_imgWednesday 19 August 2015 3:20 pm Oil prices set for long-term slump as WTI price forecast lowered through 2016 by Taboolaby TaboolaSponsored LinksSponsored LinksPromoted LinksPromoted LinksYou May LikeMoneyPailShe Was A Star, Now She Works In ScottsdaleMoneyPailMoguldom NationFather Of 2 Sues Los Angeles Hospital After Wife Dies During ChildbirthMoguldom NationSwift VerdictChrissy Metz, 39, Shows Off Massive Weight Loss In Fierce New PhotoSwift VerdictMaternity WeekA Letter From The Devil Written By A Possessed Nun In 1676 Has Been TranslatedMaternity WeekPost FunKate & Meghan Are Very Different Mothers, These Photos Prove ItPost FunComedyAbandoned Submarines Floating Around the WorldComedyGameday NewsNBA Wife Turns Heads Wherever She GoesGameday NewsEquity MirrorThey Drained Niagara Falls — They Weren’t Prepared For This Sickening DiscoveryEquity Mirrorzenherald.comMeghan Markle Changed This Major Detail On Archies Birth whatsapp Share Show Comments ▼ Clara Guibourg whatsapp Oil companies should brace themselves: the black stuff’s slump is set to be long-term, according to the US Energy Information Administration (EIA), which just lowered its oil price forecast through to the end of next year.Although prices rallied briefly yesterday on bullish US economic data, the EIA thinks this recovery is unlikely to last. Read more: Light at the end of the North Sea pipelineUS benchmark West Texas Intermediate (WTI), currently trading at $42.62 per barrel, recently crashed through its $42 floor to trade at a six-year low. According to the EIA’s new gloomier outlook, it’s unlikely to recover significantly within the next year.The agency is expecting WTI to trade at an average of $49 per barrel in 2015 and $54 in 2016, after it lowered its forecast over an uncertain global oil market:Concerns over the pace of economic growth in emerging markets, continuing (albeit slowing) supply growth, increases in global liquids inventories, and the possibility of increasing volumes of Iranian crude oil entering the market contributed to the changed forecast.The global benchmark Brent crude is trading at $48.81 per barrel. Tags: Oil priceslast_img read more

News / Agility making gains and seeing the profits, despite revenue decline

first_img“Within our global integrated logistics business, we are making gains, even in the face of a challenging freight forwarding market, because we have found ways to be more efficient, improve productivity, demonstrate financial discipline and make operations more responsive to the marketplace and customers’ needs.”The company has two main operations: logistics and infrastructure. Revenue for the much larger Agility Global Integrated Logistics (GIL) was KD233m, a 10% year-on-year decrease, which the firm said was mainly due to “low shipping and fuel rates in the market”.The division’s net revenue “remained flat when adjusted at constant currency rates, with margins expanding from 25% in the second quarter of 2015 to 27% in the second quarter this year”.Mr Sultan said: “Subdued trade forecasts for the year, to quote the WTO, continue to impact the freight forwarding market. However, Agility GIL was able to record volume growth in its core air and ocean markets and is focusing on products and markets that are growing despite sluggish overall volumes.“Growing demand for contract logistics in emerging markets – an area where Agility has long-established market leadership – coupled with improved yields in the freight business and better commercial discipline, has resulted in margin expansion within GIL.”Agility Infrastructure saw revenue grow 12% year on year to KD80m, largely due to the number of new projects in its key Middle East region. The unit provides logistics-related services such as bulk fuel storage and transport, industrial real estate, airport and ground handling services and commercial real estate and facilities management.“Companies in the Agility Infrastructure group continue to grow as we tap into excellent opportunities in emerging markets and focus on improving efficiency across the board,” Mr Sultan said.“Although the external market environment continues to be a challenge, particularly to our commercial logistics business, we are continuing to improve our financial performance by growing the Infrastructure portfolio of companies and simultaneously driving transformation of our GIL business,” he continued. By Gavin van Marle 08/08/2016 Kuwait 3PL Agility Logistics recorded marginally increased profitability in the second quarter, despite seeing diminishing revenues.Revenue of KD309m (US$1.024bn) represented a 6% decline on the KD328m posted in the second quarter of 2015.However, earnings before interest, tax, depreciation and amortisation grew 12% to 12% to reach KD29m, compared with KD26m in same period last year, while net profit grew 11% year on year to KD15m.Agility chief executive Tarek Sultan said: “We started the year on a good note and are sustaining momentum as the year progresses.last_img read more

Premium / Analysis: can Kuehne + Nagel really be eyeing a Panalpina takeover?

first_img Premium subscriber LOGIN Please either REGISTER or login below to continue Subscription required for Premium stories In order to view the entire article please login with a valid subscription below or register an account and subscribe to Premium By Alessandro Pasetti 26/11/2018 Reset Your Password New Premium subscriber REGISTER LOGIN Email* The idea that Panalpina “has to go sooner rather than later” is growing in popularity among my sources, notwithstanding public remarks made by Kuehne + Nagel management on Friday and Panalpina on Sunday.However, beware the hype. I may very well be wrong, but I doubt K+N has any serious intention to take over its smaller domestic rival in its current form, although the ousting of chairman Peter Ulber could trigger big changes in Basel.Tricky stuffOne of the most prominent freight … Password* << Go back Email* Reset Forgotten your password? Please click here Please Loginlast_img read more

Premium / Under the radar: XPO Logistics – The board wins. Again.

first_imgBy Alessandro Pasetti 18/05/2020 Password* Please either REGISTER or login below to continue Forgotten your password? Please click here The annual shareholders e-meeting at XPO Logistics was held on Thursday and, predictably, approved what the board wanted while rejecting calls for reform, mostly from the unions, that had all been opposed by the board.The votes were preceded by a great deal of union and media pressure (our previous April coverage here)…… which essentially fell on deaf ears, as those who complain that XPO isn’t doing what it should to protect its workers, quite simply, don’t own enough stock – … Subscription required for Premium stories In order to view the entire article please login with a valid subscription below or register an account and subscribe to Premium Email* Please Login New Premium subscriber REGISTER Reset Your Password LOGIN Premium subscriber LOGIN << Go back Email* Resetlast_img read more

Supreme Court asks Obama administration for views on biosimilar rules

first_img Related: Tags biologicsdrug pricespolicySupreme Court Ed Silverman In a move with implications for health care expenses, the US Supreme Court has asked the Obama administration for its views on a heated dispute over a rule that will determine when lower-cost biosimilar medicines can be launched.At issue is the ability of brand-name drug makers to delay the introduction of biosimilars, which are highly identical versions of expensive biologics. And the court wants the US solicitor general to help determine whether it should hear about a contentious battle between two big drug makers — Amgen and Sandoz — that might settle the matter.The rule in question concerns the notice that a brand-name company is entitled to receive from a drug maker that wants to sell a biosimilar. But the rule has not been previously tested because the US Food and Drug Administration so far has approved only two biosimilars.advertisement J. Scott Applewhite/AP Privacy Policy Leave this field empty if you’re human: Sandoz argued that federal law allowed it to give Amgen notice of its marketing plans 180 days before winning marketing approval from the US Food and Drug Administration. But last summer, a federal appeals court decided that biosimilar companies must wait until they actually receive FDA approval before they must provide brand-name rivals notice of a product launch. So Sandoz asked the Supreme Court to overturn the decision.Essentially, the Supreme Court is being asked to decide an important policy question because if the appeals court ruling is allowed to stand, it would serve as a broader benchmark for the entire pharmaceutical industry going forward. The rule is found in a federal law known as the Biologics Price Competition and Innovation Act, which says a company seeking to sell a biosimilar must give the manufacturer of the brand-name biologic at least a 180-day notice before selling its drug. The purpose is to provide a brand-name company time to determine what, if any, patent challenges to pursue. And the dispute centers on when the notice begins. @Pharmalot Related: How so? Brand-name drug makers already have 12 years of exclusivity for their biologic medicines, and the additional 180-day notice would give these companies still more time in which to prepare patent challenges, which can delay biosimilar launches. In effect, the difference in timing is a valuable right for biosimilar companies, as well as a valuable impediment for brand-name drug makers.A great deal is also at stake for patients and payers because biosimilars are estimated to save as much as $44 billion in US health care costs over the next decade. Many insurers and analysts forecast that biosimilars will cost 10 percent to 30 percent less than brand-name biologics, although the number is a moving target, given that companies raise biologics prices to anticipate competition.“For everyone who pays for these drugs, the additional six months of exclusivity can add up to a lot of money,” said Elaine Herrmann Blais, a partner at the Goodwin Procter law firm, which represents drug makers that sell biologics and are developing biosimilars. She is also a coauthor of the firm’s Big Molecule Watch Blog.The current dispute began last year, when Sandoz, which is the generic unit of Novartis, won the right to sell a biosimilar version of Amgen’s Neupogen, a treatment used to boost white blood cell counts in chemotherapy patients and others with compromised immune systems. But Sandoz lost a court case over the timing required to provide notice to Amgen. At first blush, 180 days may not seem like a great deal of time. But six months can be significant.advertisementcenter_img Please enter a valid email address. PharmalotSupreme Court asks Obama administration for views on biosimilar rules This explains why the Supreme Court asked the solicitor general to share its thoughts and possibly help determine the extent to which the case is important enough to review now, rather than wait for more disputes to be decided by lower courts, according to William Jay, who is also a partner at Goodwin Procter and is a former assistant to the solicitor general.“The chances that Sandoz will persuade the court to take the case have just gone up,” he said.It’s worth noting that President Obama has repeatedly called for marketing exclusivity for biologics to be held to seven years, and not 12 years, in his annual budget proposals (see page 74). But the invitation to the solicitor general marks the first opportunity for the administration to offer its interpretation of the law governing the 180-day notice, and openly decide whether to side with brand-name drug makers or biosimilar companies, Jay added.“The executive branch has to make a choice,” he said. “Does it think the best outcome for public policy is to make people wait 180 days or not” for a lower-cost medicine? Unintended twist in Obamacare may cost some Medicare patients more for biosimilars Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry. Sandoz urges Supreme Court to review biosimilar launch rules About the Author Reprints By Ed Silverman June 21, 2016 Reprints [email protected] Newsletters Sign up for Pharmalot Your daily update on the drug industry.last_img read more

Johnson & Johnson vaccines will be aimed toward newly eligible groups in Florida

first_imgRELATEDTOPICS AdvertisementDC Young Fly knocks out heckler (video) – Rolling OutRead more6 comments’Mortal Kombat’ Exceeded Expectations Says WarnerMedia ExecutiveRead more2 commentsDo You Remember Bob’s Big Boy?Read more1 commentsKISS Front Man Paul Stanley Reveals This Is The End Of KISS As A Touring Band, For RealRead more1 comments Half of Americans now fully vaccinated against COVID-19 May 26, 2021 Charlotte County public school vaccine event on Saturday May 24, 2021 Moderna trial showing promise for expanding age requirement next month May 26, 2021 Fauci says COVID-19 booster shot likely needed ‘within a year or so” May 21, 2021 “We are pleased the Governor is putting an emphasis on teachers and staff for the next round of vaccines to make our schools even safer,” said Rob Spicker in a statement. There is not a clear timeline for when the doses will be distributed.  Advertisement AdvertisementTags: Johnson & JohnsonVaccine AdvertisementHe said the state would be partnering with the different organizations to distribute the doses. Currently, the Charlotte County Sheriff’s Office said they have a plan in place. A spokesperson said the vaccine will be administered in-house by jail medical staff.School districts like the Lee County School district are currently working with the health department to figure out a plan. Rob Spicker, a spokesperson for the district, said out of the 4,000 eligible employees, about 2,000 are interested in getting the vaccine.  Advertisement AdvertisementRecommended ArticlesBrie Larson Reportedly Replacing Robert Downey Jr. As The Face Of The MCURead more81 commentsGal Gadot Reportedly Being Recast As Wonder Woman For The FlashRead more29 comments Governor Ron DeSantis announced the new allocation for the Johnson & Johnson vaccine would be aimed toward school staff, firefighters and law enforcement aged 50 and up. In a press conference Wednesday, DeSantis said he is still expecting an allocation of about 175,000 doses.“That actually is enough for us to do all law enforcement, all fire, all school-aged [employees] 50 and up in the entire state,” DeSantis said. Related Article: Governor DeSantis announces changes to vaccine eligibility, leading to confusionlast_img read more

Boman Irani appointed as brand ambassador for Circa range of devices

first_img Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” News The missing informal workers in India’s vaccine story Read Article #ShareYourPressureblood pressureBoman IraniBP monitoring deviceCirca range of devicesEris Lifescienceshypertensive patients WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals Share Related Posts Comments (0) Boman Irani appointed as brand ambassador for Circa range of devices The association is aimed at highlighting importance of accurate, validated BP monitoring deviceEris Lifesciences has announced association with the well-known theatre and film actor, Boman Irani, for their Circa range of devices. The association is aimed at highlighting importance of an accurate and validated BP monitoring device.The focus of the campaign is to encourage hypertensive patients to measure their blood pressure at home using a validated device while making an appeal to share their readings with doctor. The campaign theme #ShareYourPressure, urges users to stop worrying about getting false reading and trust the device to share their pressure.Sharing his comments on the partnership, Irani said, “It gives me immense pleasure to start this journey with Circa. For blood pressure management, the latest norms require a person to monitor it at least two times a day in the morning and evening. With technology advancing manifolds, it is only important for us to bring the same into our healthcare systems and adopt validated devices that can provide timely updates when required.”The campaign will go live on social media channels this week in the form of short videos.Commenting on the development, Amit Bakshi, Chairman and Managing Director, Eris Lifesciences said, “Hypertension therapy is our second largest therapy and with cardiovascular being the number one chronic therapy, we are upping our ante by closing the loop with one of the most validated device for blood pressure management. We have world class data in the form of ‘India Heart Study’ conducted on the same ‘Circa’ device further validating our commitment to Hypertension therapy. With Boman Irani on board, we feel this partnership with the brand will increase awareness around home blood pressure monitoring (HBPM) and bring more people to target blood pressure.” Phoenix Business Consulting invests in telehealth platform Healpha Add Comment Heartfulness group of organisations launches ‘Healthcare by Heartfulness’ COVID care app MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” By EH News Bureau on June 12, 2020 Menopause to become the next game-changer in global femtech solutions industry by 2025last_img read more

KPN lays foundations for LTE-Advanced

first_img AddThis Sharing ButtonsShare to LinkedInLinkedInLinkedInShare to TwitterTwitterTwitterShare to FacebookFacebookFacebookShare to MoreAddThisMore 18 JUN 2014 Related Home KPN lays foundations for LTE-Advanced Previous ArticleKakao climbs on mobile money bandwagonNext ArticleT-Mobile’s Legere blasts Amazon/AT&T deal Author Tags KPN in line for $15B takeover bid Tim joined Mobile World Live in August 2011 and works across all channels, with a particular focus on apps. He came to the GSMA with five years of tech journalism experience, having started his career as a reporter… More Read more Bouygues TelecomEEKPNLTE-AdvancedTechnology KPN is joining the vanguard of European operators offering LTE-Advanced services on a commercial basis via plans to deploy LTE on a second spectrum band next month.The company said it will launch 4G services on the 1.8 GHz spectrum band on 1 July, in addition to its existing services on the 800 MHz band. It said the activation of LTE-Advanced will follow “thereafter”.KPN became the first Dutch operator to offer nationwide 4G coverage in the first quarter of the year. Its next step is to combine the existing offering with the 1.8 GHz frequency using LTE-Advanced technology, which should offer theoretical peak download speeds of up to 200 Mb/s.KPN is working with Ericsson on the LTE-Advanced deployment, which will initially take place in Amsterdam, Schiphol, Rotterdam, Utrecht, The Hague and Eindhoven.From 1 July, all 4G customers will have higher download speeds of 50 Mb/s. In addition, most SIM-only and handset offerings will feature increased data allowance.LTE-Advanced services are starting to be launched commercially in Europe.France’s Bouygues Telecom announced this week that it has LTE-Advanced up and running in seven cities, although customers will have to wait until 1 July for devices able to support the technology. Bouygues can now offer theoretical peak speeds up to 220Mb/s.Switzerland’s Swisscom launched two small LTE-Advanced networks earlier this week and said it will extend the service into the cities of Berne and Biel/Bienne in early July.The UK’s largest operator EE plans to launch LTE-Advanced services by the end of the summer, starting in central London, following a small pilot last November.EE CEO Olaf Swantee told Mobile World Live that the technology will enable theoretical peak speeds of 300Mb/s, and will later rollout everywhere within the M25 motorway.South Korea is leading the way with LTE-Advanced, with the technology deployed by all three national operators, with theoretical peak download speeds soon expected to reach 300 Mb/s. Mobile broadband speeds are now so high in South Korea that operators are no longer able to differentiate by network speed.According to a 4G Americas report released this week, LTE-Advanced is now commercially deployed on nine networks in seven countries worldwide, with those numbers expected to reach 40 networks by year-end 2014. KPN snubs two takeover approaches KPN puts Ericsson in patent hotseat Tim Ferguson last_img read more

Globe sets up separate tower unit

first_img Author Home Globe sets up separate tower unit Joseph Waring Globe TelecomPLDTtower sharing Joseph Waring joins Mobile World Live as the Asia editor for its new Asia channel. Before joining the GSMA, Joseph was group editor for Telecom Asia for more than ten years. In addition to writing features, news and blogs, he… Read more Philippines mobile operator Globe Telecom moved to divest its tower assets, informing the Philippine Stock Exchange it began the process of incorporating a separate holding company.The operator said in a statement that once it receives approval from the country’s Securities and Exchange Commission, the divestment of all or part of its tower assets through a separate company will be operational.In February Globe initiated discussions with third parties about setting up a tower company to speed deployment of cellular towers across the country. At the time, the company said it was looking at divesting all or part of its tower assets, totalling more than 8,000 sites nationwide, to an independent tower company as part of its network expansion and optimisation plan.Ernest Cu, president and CEO of Globe, said it pushed to establish tower companies similar to those found in other developed countries: “This initiative will help accelerate the deployment of more cellular towers in the Philippines and foster competition,” he added.With the proposed holding company, the company said any player can lease space in the towers using standard, non-discriminatory commercial terms.“Putting up more towers based on global standards within strategic areas will make spectrum use more efficient. We should work together and find all means to supplement the build for towers, either through telcos or tower companies,” Cu said, adding it remains open to collaboration with new and existing players in the interest of national development.In early May he suggested Globe would consider cooperating with rival PLDT or a planned third operator in the Philippines to create an independent tower company to reduce its rising capex: a proposal rejected by rival PLDT, parent company of Smart Communications. Related Previous ArticleMobile Mix: Episode 5Next ArticleXiaomi set for Hong Kong debut center_img Asia Globe Telecom profit climbs PLDT accelerates network investment with focus on 5G Globe asseses satellite internet options Tags AddThis Sharing ButtonsShare to LinkedInLinkedInLinkedInShare to TwitterTwitterTwitterShare to FacebookFacebookFacebookShare to MoreAddThisMore 06 JUL 2018 last_img read more

8 new confirmed cases of Covid-19 in Ireland

first_img WhatsApp Previous articleHomes without power this afternoon around BallyshannonNext articleSuccessful day at Leopardstown for Oisin Orr News Highland DL Debate – 24/05/21 Important message for people attending LUH’s INR clinic Nine til Noon Show – Listen back to Monday’s Programme Pinterest 8 new confirmed cases of Covid-19 in Ireland Facebook Google+ Facebook A further one person has died with Covid 19 in the Republic bringing the death toll since the outbreak began to 1,706.The Health Protection Surveillance Centre says there are 8 new confirmed cases of virus, to give an total of 25,303.Of those for whom transmission status is known: community transmission accounts for 37%, close contact makes up 60% and travel abroad accounts for 2%. Pinterestcenter_img WhatsApp Homepage BannerNews Twitter Twitter News, Sport and Obituaries on Monday May 24th Loganair’s new Derry – Liverpool air service takes off from CODA By News Highland – June 14, 2020 Arranmore progress and potential flagged as population grows Google+ RELATED ARTICLESMORE FROM AUTHORlast_img read more